LVGO

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

The virtual health clinic has launched to serve 60M+ Americans suffering from GI issues Salvo Health (https://www.salvohealth.com/), the virtual health clinic focusing on specialty care for chronic gut conditions, today announced the close of a $10.5 million seed funding investment led by Threshold Ventures along with Torch Capital and Felicis. These investors were early backers of healthcare innovators such as Livongo, Ro, and Brightline. Additional seed investors include founders from health transformers such as Ginger and Forward Health. Salvo Health is the first digital healthcare clinic delivering comprehensive and continuous gastro care. Members have unlimited messaging access to a

JACKSONVILLE, Fla., Oct. 16, 2020 /PRNewswire/ -- GuideWell Mutual Holding Corporation (GuideWell), the parent to a family of forward-thinking companies focused on transforming health care, announced a strategic agreement today with Livongo (Nasdaq: LVGO) the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives. Florida Blue, a GuideWell subsidiary and the Blue Cross and Blue Shield plan of Florida, will provide access to Livongo for Diabetes to select members. Access to Livongo for Diabetes will be provided through GuideWell's consumer engagement solution, Onlife Health, which helps guide health plan members through their he

NEW YORK, Oct. 16, 2020 /PRNewswire/ -- The era of telehealth is upon us. As patients try to avoid hospital rooms right now, a growing number of people have turned to telehealth from the comfort of their home to limit contact with potentially infectious areas and people. U.S. President Donald Trump recently signed an executive order giving telehealth a broader role under Medicare. And, thanks to major advances in information and technology, the global telehealth market is expected to reach $185.66 billion by 2026 at a CAGR of 23.5%. This all bodes well for companies like Teladoc Health Inc. (NYSE: TDOC), CVS Health Corp. (NYSE: CVS), Livongo Health Inc. (NASDAQ: LVGO), 1Life Healthcare In

MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Given the pending transaction with Teladoc Health, Livongo is not hosting a conference call in conjunction with its third quarter of 2020 earnings release. About Livongo Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the category of Applied Health Signals to offer Members

NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ:LVGO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of LVGO to Teladoc Health, Inc. for 0.5920x Teladoc shares plus cash consideration of $11.33 per share. If you are a LVGO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com. Varian Medical Systems, Inc. (NYSE: VAR) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection wit

NEW YORK, Sept. 25, 2020 /PRNewswire/ -- The medical device market is seeing steady growth thanks to new technologies and an emerging medical infrastructure around the world. Developing economies, which are investing more in healthcare, are also driving the expansion of the medical device market. Thus, by 2022, more than 30% of the global healthcare spending is expected to be from emerging economies. In developing countries, medical device companies leverage low manufacturing and labor costs to generate larger profit margins for investors. As a result, the medical device market is projected to grow by USD 134.2 Billion during the period of 2020-2024 and at a CAGR of over 5%, according to

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of Immunomedics to Gilead Sciences, Inc. for $88.00 per share in cash. If you are a IMMU investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com. Livongo Health, Inc. (NASDAQ:LVGO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of LVGO to Teladoc Health, Inc. for 0.59